Liver transplantation for hepatocellular carcinoma: how far can we push the envelope? - Suppr | 超能文献

Liver transplantation for hepatocellular carcinoma: how far can we push the envelope?

作者信息

Tan K C

机构信息

Gleneagles Medical Centre, 6 Napier Road, Suite #04-14/15, Singapore 228499.

出版信息

Singapore Med J. 2003 Jun;44(6):309-11.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Liver transplantation for hepatocellular carcinoma: how far can we push the envelope?

Singapore Med J. 2003 Jun;44(6):309-11.

2

Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome.儿童肝细胞癌及活体肝移植对预后的影响。

Pediatr Transplant. 2006 Feb;10(1):42-7. doi: 10.1111/j.1399-3046.2005.00395.x.

3

Liver transplantation: the preferred treatment for early hepatocellular carcinoma in the setting of cirrhosis?肝移植：肝硬化背景下早期肝细胞癌的首选治疗方法？

Ann Surg Oncol. 2007 Feb;14(2):548-52. doi: 10.1245/s10434-006-9157-y. Epub 2006 Sep 29.

4

Advances and controversies in liver transplantation: hepatocellular cancer, viral hepatitis, and living donor liver transplantation in adults. AASLD/ILTS liver transplantation course. October 27, 2000.肝移植的进展与争议：成人肝细胞癌、病毒性肝炎及活体供肝肝移植。美国肝病研究学会/国际肝脏移植学会肝移植课程。2000年10月27日。

Liver Transpl. 2000 Nov;6(6 Suppl 2):S1-80. doi: 10.1053/jlts.2000.2013.

5

Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation?--no, never.我们应该扩大活体肝移植治疗肝细胞癌的标准吗？——不，绝不。

J Hepatol. 2005 Oct;43(4):573-7. doi: 10.1016/j.jhep.2005.07.017.

6

[Living donor liver transplantation for the patient with hepatocellular carcinoma].[肝细胞癌患者的活体供肝肝移植]

Gan To Kagaku Ryoho. 2004 Dec;31(13):2118-21.

7

Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver.非肝硬化性肝脏来源的肝细胞癌肝切除的长期结果

Arch Surg. 2004 Mar;139(3):320-5; discussion 326. doi: 10.1001/archsurg.139.3.320.

8

Recurrent hepatocellular carcinoma after living donor liver transplantation: a preventable problem or an acceptable risk?活体肝移植后复发性肝细胞癌：一个可预防的问题还是可接受的风险？

Ann Surg Oncol. 2010 Sep;17(9):2262-3. doi: 10.1245/s10434-010-1099-8.

9

Should we expand the criteria for liver transplantation for hepatocellular carcinoma--yes, of course!我们应该扩大肝细胞癌肝移植的标准吗？——当然应该！

J Hepatol. 2005 Oct;43(4):569-73. doi: 10.1016/j.jhep.2005.07.016.

10

Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation?肝细胞癌的肝移植标准在尸体供肝和活体供肝中是否应该有所不同？

Liver Transpl. 2011 Oct;17 Suppl 2:S133-8. doi: 10.1002/lt.22348.

引用本文的文献

1

Liver transplantation for hepatocellular carcinoma.肝细胞癌的肝移植

Liver Cancer. 2013 Aug;2(3-4):338-44. doi: 10.1159/000343849.

2

The value of serum alpha-fetoprotein in predicting tumor recurrence after liver transplantation for hepatocellular carcinoma.血清甲胎蛋白在预测肝细胞癌肝移植术后肿瘤复发中的价值。

Dig Dis Sci. 2009 Feb;54(2):385-8. doi: 10.1007/s10620-008-0349-0. Epub 2008 Jun 18.